Drugs / Guanxinning Tablets
Guanxinning Tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07139639 | Nov 2025 → Nov 2027 expected | diabetic peripheral angiopathy | Zheng Liu | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Guanxinning Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07139639 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a herbal formula” NCT07139639 ↗ |
| Route | Oral | “4 tablets orally, three times daily for 6 months” NCT07139639 ↗ |